000271104 001__ 271104
000271104 005__ 20240818004533.0
000271104 0247_ $$2pmid$$apmid:38439203
000271104 0247_ $$2doi$$a10.1002/oby.23996
000271104 0247_ $$2ISSN$$a1071-7323
000271104 0247_ $$2ISSN$$a1930-7381
000271104 0247_ $$2ISSN$$a1550-8528
000271104 0247_ $$2ISSN$$a1930-739X
000271104 0247_ $$2altmetric$$aaltmetric:160339370
000271104 037__ $$aDZNE-2024-00976
000271104 082__ $$a610
000271104 1001_ $$aMeroni, Marica$$b0
000271104 245__ $$aHepatic and adipose tissue transcriptome analysis highlights a commonly deregulated autophagic pathway in severe MASLD
000271104 260__ $$aHoboken, NJ$$bWiley$$c2024
000271104 3367_ $$2DRIVER$$aarticle
000271104 3367_ $$2DataCite$$aOutput Types/Journal article
000271104 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1723628468_28438
000271104 3367_ $$2BibTeX$$aARTICLE
000271104 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000271104 3367_ $$00$$2EndNote$$aJournal Article
000271104 520__ $$aThe incidence of metabolic dysfunction-associated steatotic liver disease (MASLD) is rapidly ramping up due to the spread of obesity, which is characterized by expanded and dysfunctional visceral adipose tissue (VAT). Previous studies have investigated the hepatic transcriptome across MASLD, whereas few studies have focused on VAT.We performed RNA sequencing in 167 hepatic samples from patients with obesity and in a subset of 79 matched VAT samples. Circulating cathepsin D (CTSD), a lysosomal protease, was measured by ELISA, whereas the autophagy-lysosomal pathway was assessed by Western blot in hepatic and VAT samples (n = 20).Inflammation, extracellular matrix remodeling, and mitochondrial dysfunction were upregulated in severe MASLD in both tissues, whereas autophagy and oxidative phosphorylation were reduced. Tissue comparative analysis revealed 13 deregulated genes, including CTSD, which showed the most robust diagnostic accuracy in discriminating mild and severe MASLD. CTSD expression correlated with circulating protein, whose increase was further validated in 432 histologically characterized MASLD patients, showing a high accuracy in foreseeing severe liver injury. In addition, the assessment of serum CTSD increased the performance of fibrosis 4 in diagnosing advanced disease.By comparing the hepatic and VAT transcriptome during MASLD, we refined the concept by which CTSD may represent a potential biomarker of severe disease.
000271104 536__ $$0G:(DE-HGF)POF4-354$$a354 - Disease Prevention and Healthy Aging (POF4-354)$$cPOF4-354$$fPOF IV$$x0
000271104 588__ $$aDataset connected to CrossRef, Journals: pub.dzne.de
000271104 7001_ $$0P:(DE-2719)9001921$$aDe Caro, Emilia$$b1$$udzne
000271104 7001_ $$aChiappori, Federica$$b2
000271104 7001_ $$aLongo, Miriam$$b3
000271104 7001_ $$aPaolini, Erika$$b4
000271104 7001_ $$aMosca, Ettore$$b5
000271104 7001_ $$aMerelli, Ivan$$b6
000271104 7001_ $$aLombardi, Rosa$$b7
000271104 7001_ $$aBadiali, Sara$$b8
000271104 7001_ $$aMaggioni, Marco$$b9
000271104 7001_ $$aOrro, Alessandro$$b10
000271104 7001_ $$aMezzelani, Alessandra$$b11
000271104 7001_ $$aValenti, Luca$$b12
000271104 7001_ $$aFracanzani, Anna Ludovica$$b13
000271104 7001_ $$00000-0003-4343-7213$$aDongiovanni, Paola$$b14
000271104 773__ $$0PERI:(DE-600)2027211-X$$a10.1002/oby.23996$$gVol. 32, no. 5, p. 923 - 937$$n5$$p923 - 937$$tObesity$$v32$$x1071-7323$$y2024
000271104 8564_ $$uhttps://pub.dzne.de/record/271104/files/DZNE-2024-00976%20SUP.zip
000271104 8564_ $$uhttps://pub.dzne.de/record/271104/files/DZNE-2024-00976.pdf$$yOpenAccess
000271104 8564_ $$uhttps://pub.dzne.de/record/271104/files/DZNE-2024-00976.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000271104 909CO $$ooai:pub.dzne.de:271104$$pdnbdelivery$$pdriver$$pVDB$$popen_access$$popenaire
000271104 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9001921$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b1$$kDZNE
000271104 9131_ $$0G:(DE-HGF)POF4-354$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vDisease Prevention and Healthy Aging$$x0
000271104 9141_ $$y2024
000271104 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-10-24
000271104 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2023-10-24
000271104 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2023-10-24
000271104 915__ $$0LIC:(DE-HGF)CCBYNCND4$$2HGFVOC$$aCreative Commons Attribution-NonCommercial-NoDerivs CC BY-NC-ND 4.0
000271104 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bOBESITY : 2022$$d2023-10-24
000271104 915__ $$0StatID:(DE-HGF)3001$$2StatID$$aDEAL Wiley$$d2023-10-24$$wger
000271104 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2023-10-24
000271104 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-10-24
000271104 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000271104 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bOBESITY : 2022$$d2023-10-24
000271104 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-10-24
000271104 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-10-24
000271104 9201_ $$0I:(DE-2719)5000082$$kAG Aschenbrenner$$lAging and Immunity$$x0
000271104 980__ $$ajournal
000271104 980__ $$aVDB
000271104 980__ $$aUNRESTRICTED
000271104 980__ $$aI:(DE-2719)5000082
000271104 9801_ $$aFullTexts